Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study

被引:184
作者
Gong, Q. [1 ,5 ]
Gregg, E. W. [2 ]
Wang, J. [3 ]
An, Y. [1 ]
Zhang, P. [2 ]
Yang, W. [1 ]
Li, H.
Li, H.
Jiang, Y. [3 ]
Shuai, Y. [1 ]
Zhang, B. [1 ]
Zhang, J. [3 ]
Gerzoff, R. B. [2 ]
Roglic, G. [4 ]
Hu, Y. [3 ]
Li, G. [1 ]
Bennett, P. H. [5 ]
机构
[1] China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China
[2] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA
[3] Da Qing First Hosp, Dept Cardiol, Da Qing, Peoples R China
[4] World Hlth Org, Dept Chron Dis & Hlth Promot, Geneva, Switzerland
[5] NIDDKD, Diabet Epidemiol & Clin Res Sect, NIH, Phoenix, AZ USA
关键词
Diabetic retinopathy; Impaired glucose tolerance; Lifestyle intervention; Nephropathy; Neuropathy; VASCULAR-DISEASE; PREVALENCE; RETINOPATHY; MORTALITY; IGT; MELLITUS; AGE;
D O I
10.1007/s00125-010-1948-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We determined the effects of 6 years of lifestyle intervention in persons with impaired glucose tolerance (IGT) on the development of retinopathy, nephropathy and neuropathy over a 20 year period. In 1986, 577 adults with IGT from 33 clinics in Da Qing, China were randomly assigned by clinic to a control group or one of three lifestyle intervention groups (diet, exercise, and diet plus exercise). Active intervention was carried out from 1986 to 1992. In 2006 we conducted a 20 year follow-up study of the original participants to compare the incidence of microvascular complications in the combined intervention group vs the control group. Follow-up information was obtained on 542 (94%) of the 577 original participants. The cumulative incidence of severe retinopathy was 9.2% in the combined intervention group and 16.2% in the control group (p = 0.03, log-rank test). After adjusting for clinic and age, the incidence of severe retinopathy was 47% lower in the intervention group than the control group (hazard rate ratio 0.53, 95% CI 0.29-0.99, p = 0.048). No significant differences were found in the incidence of severe nephropathy (hazard rate ratio 1.05, 95% CI 0.16-7.05, intervention vs control, p = 0.96) or in the prevalence of neuropathy (8.6% vs 9.1%, p = 0.89) among the 20 year survivors. Lifestyle intervention for 6 years in IGT was associated with a 47% reduction in the incidence of severe, vision-threatening retinopathy over a 20 year interval, primarily due to the reduced incidence of diabetes in the intervention group. However, similar benefits were not seen for nephropathy or neuropathy.
引用
收藏
页码:300 / 307
页数:8
相关论文
共 27 条
  • [1] Calculating the number needed to treat for trials where the outcome is time to an event
    Altman, DG
    Andersen, PK
    [J]. BRITISH MEDICAL JOURNAL, 1999, 319 (7223) : 1492 - 1495
  • [2] [Anonymous], 1985, World Health Organ Tech Rep Ser, V727, P1
  • [3] [Anonymous], 1991, Ophthalmology, V98, P786
  • [4] Diabetic somatic neuropathies
    Boulton, AJM
    Malik, RA
    Arezzo, JC
    Sosenko, JM
    [J]. DIABETES CARE, 2004, 27 (06) : 1458 - 1486
  • [5] 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
    Bray, G. A.
    Chatellier, A.
    Duncan, C.
    Greenway, F. L.
    Levy, E.
    Ryan, D. H.
    Polonsky, K. S.
    Tobian, J.
    Ehrmann, D.
    Matulik, M. J.
    Clark, B.
    Czech, K.
    DeSandre, C.
    Hilbrich, R.
    McNabb, W.
    Semenske, A. R.
    Goldstein, B. J.
    Smith, K. A.
    Wildman, W.
    Pepe, C.
    Goldberg, R. B.
    Calles, J.
    Ojito, J.
    Castillo-Florez, S.
    Florez, H. J.
    Giannella, A.
    Lara, O.
    Veciana, B.
    Haffner, S. M.
    Montez, M. G.
    Lorenzo, C.
    Martinez, A.
    Hamman, R. F.
    Testaverde, L.
    Bouffard, A.
    Dabelea, D.
    Jenkins, T.
    Lenz, D.
    Perreault, L.
    Price, D. W.
    Steinke, S. C.
    Horton, E. S.
    Poirier, C. S.
    Swift, K.
    Caballero, E.
    Jackson, S. D.
    Lambert, L.
    Lawton, K. E.
    Ledbury, S.
    Kahn, S. E.
    [J]. LANCET, 2009, 374 (9702) : 1677 - 1686
  • [6] Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO multinational study of vascular disease in diabetes
    Chi, ZS
    Lee, ET
    Lu, M
    Keen, H
    Bennett, PH
    [J]. DIABETOLOGIA, 2001, 44 (Suppl 2) : S82 - S86
  • [7] Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial
    Gerstein, H. C.
    Yusuf, S.
    Holman, R. R.
    Bosch, J.
    Anand, S.
    Avezum, A.
    Budaj, A.
    Chiasson, J.
    Conget, I.
    Dagenais, G.
    Davis, M.
    Diaz, R.
    Dinccag, N.
    Enjalbert, M.
    Escalante, A.
    Fodor, G.
    Hanefeld, M.
    Hedner, T.
    Jolly, K.
    Keltai, M.
    Laakso, M.
    Lanas, F.
    Lonn, E.
    McQueen, M.
    Mohan, V.
    Phillips, A.
    Piegas, L.
    Pirags, V.
    Probstfield, J.
    Shaw, J.
    Schmid, I.
    Teo, K.
    Zimmet, P.
    Zinman, B.
    Gerstein, H. C.
    Yusuf, S.
    Bosch, J.
    Pogue, J.
    Sheridan, P.
    Dinccag, N.
    Hanefeld, M.
    Hoogwerf, B.
    Laakso, M.
    Mohan, V.
    Shaw, J.
    Zinman, B.
    Holman, R. R.
    Diaz, R.
    Ahuad Guerrero, R.
    Albisu, J.
    [J]. LANCET, 2006, 368 (9541) : 1096 - 1105
  • [8] Mortality trends in men and women with diabetes, 1971 to 2000
    Gregg, Edward W.
    Gu, Qiuping
    Cheng, Yiling J.
    Narayan, Venkat
    Cowie, Catherine C.
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 147 (03) : 149 - 155
  • [9] Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes -: 1999-2000 National Health and Nutrition Examination Survey
    Gregg, EW
    Sorlie, P
    Paulose-Ram, R
    Gu, QP
    Eberhardt, MS
    Wolz, M
    Burt, V
    Curtin, L
    Engelgau, M
    Geiss, L
    [J]. DIABETES CARE, 2004, 27 (07) : 1591 - 1597
  • [10] CORONARY HEART-DISEASE AND DIABETIC-RETINOPATHY IN NEWLY DIAGNOSED DIABETES IN DA-QING, CHINA - THE DA-QING IGT AND DIABETES STUDY
    HU, YH
    PAN, XR
    LIU, PA
    LI, GW
    HOWARD, BV
    BENNETT, PH
    [J]. ACTA DIABETOLOGICA, 1991, 28 (02) : 169 - 173